Human muscular fetal cells: A potential cell source for muscular therapies

Pediatric Surgery International

Volumn 24, Issue 1, 2008, Pages 37-47

  Hirt Burri, Nathalie ^a   De Buys Roessingh, Anthony S ^a   Scaletta, Corinne ^a,b   Gerber, Stefan ^a   Pioletti, Dominique P ^b   Applegate, Lee Ann ^a,b   Hohlfeld, Judith ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

Cell therapy; Fetal cells; Muscle; Myoblast transplantation; Tissue engineering

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; CELL DIFFERENTIATION; CELL ISOLATION; CELL THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; CRYOPRESERVATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; MUSCLE BIOPSY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING;

ADOLESCENT; ADULT; ANIMALS; BIOPSY; CELL SURVIVAL; CELLS, CULTURED; DESMIN; DNA; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOBLASTS, SKELETAL; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 37749033161     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-007-2040-5     Document Type: Conference Paper

References (66)

1. Partridge T (2002) Myoblast transplantation. Neuromuscul Disord 12(Suppl 1):S3-S6
2. Skuk D, Tremblay JP (2000) Progress in myoblast transplantation: a potential treatment of dystrophies. Microsc Res Tech 48:213-222
3. Skuk D, Vilquin JT, Tremblay JP (2002) Experimental and therapeutic approaches to muscular dystrophies. Curr Opin Neurol 15:563-569
4. Skuk D, Tremblay JP (2003) Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil 24:285-300
5. Menasche P (2005) Skeletal myoblast for cell therapy. Coron Artery Dis 16:105-110
6. Huard J, Li Y, Fu FH (2002) Muscle injuries and repair: current trends in research. J Bone Joint Surg Am 84-A:822-832
7. Partridge T (2002) Myoblast transplantation. Neuromuscul Disord 12(Suppl 1):S3-S6
8. Partridge TA, Grounds M, Sloper JC (1978) Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273:306-308
9. Menasche P (2005) Skeletal myoblast for cell therapy. Coron Artery Dis 16:105-110
10. Partridge TA, Grounds M, Sloper JC (1978) Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 273:306-308
11. Skuk D, Roy B, Goulet M, Tremblay JP (1999) Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol 155:22-30
12. Partridge T (2002) Myoblast transplantation. Neuromuscul Disord 12(Suppl 1):S3-S6
13. Skuk D, Tremblay JP (2000) Progress in myoblast transplantation: a potential treatment of dystrophies. Microsc Res Tech 48:213-222
14. Partridge T (2002) Myoblast transplantation. Neuromuscul Disord 12(Suppl 1):S3-S6
15. Smythe GM, Hodgetts SI, Grounds MD (2000) Immunobiology and the future of myoblast transfer therapy. Mol Ther 1:304-313
16. Beauchamp JR, Pagel CN, Partridge TA (1997) A dual-marker system for quantitative studies of myoblast transplantation in the mouse. Transplantation 63:1794-1797
17. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA (1999) Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144:1113-1122
18. Fan Y, Maley M, Beilharz M, Grounds M (1996) Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19:853-860
19. Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD (2000) Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 9:489-502
20. Hodgetts SI, Spencer MJ, Grounds MD (2003) A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation. Transplantation 75:863-871
21. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267
22. Rando TA, Pavlath GK, Blau HM (1995) The fate of myoblasts following transplantation into mature muscle. Exp Cell Res 220:383-389
23. Sammels LM, Bosio E, Fragall CT, Grounds MD, van Rooijen N, Beilharz MW (2004) Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 77:1790-1797
24. Fan Y, Maley M, Beilharz M, Grounds M (1996) Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19:853-860
25. Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD (2000) Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 9:489-502
26. Tambara K, Sakakibara Y, Sakaguchi G, Lu F, Premaratne GU, Lin X, Nishimura K, Komeda M (2003) Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108(Suppl 1):II259-II263
27. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267
28. Pavlath GK, Rando TA, Blau HM (1994) Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol 127:1923-1932
29. Guerette B, Skuk D, Celestin F, Huard C, Tardif F, Asselin I, Roy B, Goulet M, Roy R, Entman M, Tremblay JP (1997) Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol 159:2522-2531
30. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L, Innocenzi A, Galvez BG, Messina G, Morosetti R, Li S, Belicchi M, Peretti G, Chamberlain JS, Wright WE, Torrente Y, Ferrari S, Bianco P, Cossu G (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255-267
31. Maurel A, Azarnoush K, Sabbah L, Vignier N, Le Lorc'h M, Mandet C, Bissery A, Garcin I, Carrion C, Fiszman M, Bruneval P, Hagege A, Carpentier A, Vilquin JT, Menasche P (2005) Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? Transplantation 80:660-665
32. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142:1257-1267
33. Jankowski RJ, Haluszczak C, Trucco M, Huard J (2001) Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther 12:619-628
34. Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP (1994) High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 93:586-599
35. Torrente Y, Tremblay JP, Pisati F, Belicchi M, Rossi B, Sironi M, Fortunato F, El Fahime M, D'Angelo MG, Caron NJ, Constantin G, Paulin D, Scarlato G, Bresolin N (2001) Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 152:335-348
36. Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM (2005) Stem cells. Lancet 366:592-602
37. Deasy BM, Jankowski RJ, Huard J (2001) Muscle-derived stem cells: characterization and potential for cell-mediated therapy. Blood Cells Mol Dis 27:924-933
38. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705
39. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L., Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106
40. Gang EJ, Jeong JA, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C, Han H,Kim H (2004) Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22:617-624
41. De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L., Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106
42. Barry FP, Murphy JM (2004) Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584
43. Bullard KM, Longaker MT, Lorenz HP (2003) Fetal wound healing: current biology. World J Surg 27:54-61
44. Bhattacharya N (2004) Fetal cell/tissue therapy in adult disease: a new horizon in regenerative medicine. Clin Exp Obstet Gynecol 31:167-173
45. Hohlfeld J, De Buys Roessingh AS, Hirt-Burri N, Chaubert P, Gerber S, Scaletta C, Hohlfeld P, Applegate LA (2005) Tissue engineered fetal skin constructs for paediatric burns. The Lancet 366:840-842
46. Montjovent MO, Burri N, Mark S, Federici E, Scaletta C, Zambelli PY, Hohlfeld P, Leyvraz PF, Applegate LA, Pioletti DP (2004) Fetal bone cells for tissue engineering. Bone 35:1323-1333
47. De Buys Roessingh AS, Hohlfeld J, Scaletta C, Hirt-Burri N, Gerber S, Hohlfeld P, Gebbers JO,Applegate LA (2006) Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing. Cell Transplant 15:823-834
48. Crombleholme TM, Langer JC, Harrison MR, Zanjani ED (1991) Transplantation of fetal cells. Am J Obstet Gynecol 164:218-230
49. Gabbianelli M, Boccoli G, Petti S, Cianetti L, La Valle R, Ferbus D, Mastroberardino G, Testa U, Peschle C (1987) Expression and in-vitro modulation of HLA antigens in ontogenic development of human hemopoietic system. Ann N Y Acad Sci 511:138-147
50. Clarkson ED (2001) Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results. Drugs Aging 18:773-785
51. Bachoud-Levi AC, Gaura V, Brugieres P, Lefaucheur JP, Boisse MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M (2006) Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5:303-309
52. Peterson CM, Jovanovic-Peterson L, Formby B, Gondos B, Monda LM, Walker L, Rashbaum W, Williams K (1989) Human fetal pancreas transplants. J Diabet Complications 3:27-34
53. Pioletti DP, Montjovent MO, Zambelli PY, Applegate LA (2006) Bone tissue engineering using foetal cell therapy. Swiss Med Wkly 136:557-560
54. Montjovent MO, Burri N, Mark S, Federici E, Scaletta C, Zambelli PY, Hohlfeld P, Leyvraz PF, Applegate LA, Pioletti DP (2004) Fetal bone cells for tissue engineering. Bone 35:1323-1333
55. Quintin A, Hirt-Burri N, Scaletta C, Schizas C, Pioletti DP, Applegate LA (2007) Consistency of fetal cell banks for research and clinical use. Cell Transplant (in press)
56. Montjovent MO, Burri N, Mark S, Federici E, Scaletta C, Zambelli PY, Hohlfeld P, Leyvraz PF, Applegate LA, Pioletti DP (2004) Fetal bone cells for tissue engineering. Bone 35:1323-1333
57. Walsh FS, Ritter MA (1981) Surface antigen differentiation during human myogenesis in culture. Nature 289:60-64
58. Schafer R, Knauf U, Zweyer M, Hogemeier O, de Guarrini F, Liu X, Eichhorn HJ, Koch FW, Mundegar RR, Erzen I, Wernig A (2006) Age dependence of the human skeletal muscle stem cell in forming muscle tissue. Artif Organs 30:130-140
59. Schafer R, Knauf U, Zweyer M, Hogemeier O, de Guarrini F, Liu X, Eichhorn HJ, Koch FW, Mundegar RR, Erzen I, Wernig A (2006) Age dependence of the human skeletal muscle stem cell in forming muscle tissue. Artif Organs 30:130-140
60. Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD (2000) Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 9:489-502
61. Fan Y, Beilharz MW, Grounds MD (1996) A potential alternative strategy for myoblast transfer therapy: the use of sliced muscle grafts. Cell Transplant 5:421-429
62. Tambara K, Sakakibara Y, Sakaguchi G, Lu F, Premaratne GU, Lin X, Nishimura K, Komeda M (2003) Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108(Suppl 1):II259-II263
63. Sakai T, Li RK, Weisel RD, Mickle DA, Jia ZQ, Tomita S, Kim EJ, Yau TM (1999) Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg 118:715-724
64. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, Butler-Browne GS (1997) Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther 8:1429-1438
65. Skuk D, Roy B, Goulet M, Chapdelaine P, Bouchard JP, Roy R, Dugre FJ, Lachance JG, Deschenes L, Helene S, Sylvain M, Tremblay JP (2004) Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 9:475-482
66. Skuk D, Goulet M, Roy B, Piette V, Cote CH, Chapdelaine P, Hogrel JY, Paradis M, Bouchard JP, Sylvain M, Lachance JG, Tremblay JP (2007) First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul Disord 17:38-46